Tolmeijer, S.H.; Koornstra, R.H.T.; de Groot, J.W.B.; Geerlings, M.J.; van Rens, D.H.; Boers-Sonderen, M.J.; Schalken, J.A.; Gerritsen, W.R.; Ligtenberg, M.J.L.; Mehra, N.
Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma. Cancers 2021, 13, 3913.
https://doi.org/10.3390/cancers13153913
AMA Style
Tolmeijer SH, Koornstra RHT, de Groot JWB, Geerlings MJ, van Rens DH, Boers-Sonderen MJ, Schalken JA, Gerritsen WR, Ligtenberg MJL, Mehra N.
Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma. Cancers. 2021; 13(15):3913.
https://doi.org/10.3390/cancers13153913
Chicago/Turabian Style
Tolmeijer, Sofie H., Rutger H. T. Koornstra, Jan Willem B. de Groot, Maartje J. Geerlings, Dirk H. van Rens, Marye J. Boers-Sonderen, Jack A. Schalken, Winald R. Gerritsen, Marjolijn J. L. Ligtenberg, and Niven Mehra.
2021. "Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma" Cancers 13, no. 15: 3913.
https://doi.org/10.3390/cancers13153913
APA Style
Tolmeijer, S. H., Koornstra, R. H. T., de Groot, J. W. B., Geerlings, M. J., van Rens, D. H., Boers-Sonderen, M. J., Schalken, J. A., Gerritsen, W. R., Ligtenberg, M. J. L., & Mehra, N.
(2021). Plasma BRAF Mutation Detection for the Diagnostic and Monitoring Trajectory of Patients with LDH-High Stage IV Melanoma. Cancers, 13(15), 3913.
https://doi.org/10.3390/cancers13153913
